Potential benefits and risks of testosterone treatment in older men

madman

Super Moderator


Shalender Bhasin, M.D., Professor of Medicine at Harvard Medical School, and Director, Boston Claude D. Pepper Older Americans Independence Center; Director, Brigham Research Assay Core Laboratory; Director, Research Program in Men's Health: Aging and Metabolism; and Co-Director, The Center for Transgender Health at Brigham and Women's Hospital, presented the 2022 Beverly Todd Towery Lecture, "A Patient-Centric, Evidence-based Approach to the Management of Older Men with Age-Related Decline in Testosterone Levels" at University of Louisville Department of Medicine Grand Rounds on March 3, 2022

Dr. Bhasin's talk focused on recognizing the potential benefits and risks of testosterone treatment in older men, determining which older men might be candidates for testosterone treatment, and establishing a standardized monitoring plan to optimize the benefit to risk ratio.


Presented by the UofL Division of Endocrinology, Metabolism & Diabetes






Screenshot (11255).png

Screenshot (11256).png

Screenshot (11257).png

Screenshot (11258).png

Screenshot (11259).png

Screenshot (11260).png

Screenshot (11261).png
 


Shalender Bhasin, M.D., Professor of Medicine at Harvard Medical School, and Director, Boston Claude D. Pepper Older Americans Independence Center; Director, Brigham Research Assay Core Laboratory; Director, Research Program in Men's Health: Aging and Metabolism; and Co-Director, The Center for Transgender Health at Brigham and Women's Hospital, presented the 2022 Beverly Todd Towery Lecture, "A Patient-Centric, Evidence-based Approach to the Management of Older Men with Age-Related Decline in Testosterone Levels" at University of Louisville Department of Medicine Grand Rounds on March 3, 2022

Dr. Bhasin's talk focused on recognizing the potential benefits and risks of testosterone treatment in older men, determining which older men might be candidates for testosterone treatment, and establishing a standardized monitoring plan to optimize the benefit to risk ratio.

Presented by the UofL Division of Endocrinology, Metabolism & Diabetes







View attachment 20041
View attachment 20042
View attachment 20043
View attachment 20044
View attachment 20045
View attachment 20046
View attachment 20047
Thank you very much for posting this!
 


Shalender Bhasin, M.D., Professor of Medicine at Harvard Medical School, and Director, Boston Claude D. Pepper Older Americans Independence Center; Director, Brigham Research Assay Core Laboratory; Director, Research Program in Men's Health: Aging and Metabolism; and Co-Director, The Center for Transgender Health at Brigham and Women's Hospital, presented the 2022 Beverly Todd Towery Lecture, "A Patient-Centric, Evidence-based Approach to the Management of Older Men with Age-Related Decline in Testosterone Levels" at University of Louisville Department of Medicine Grand Rounds on March 3, 2022

Dr. Bhasin's talk focused on recognizing the potential benefits and risks of testosterone treatment in older men, determining which older men might be candidates for testosterone treatment, and establishing a standardized monitoring plan to optimize the benefit to risk ratio.

Presented by the UofL Division of Endocrinology, Metabolism & Diabetes







View attachment 20041
View attachment 20042
View attachment 20043
View attachment 20044
View attachment 20045
View attachment 20046
View attachment 20047
I do find it unfortunate that in response to the last question in the talk Dr.


Shalender Bhasin, M.D., Professor of Medicine at Harvard Medical School, and Director, Boston Claude D. Pepper Older Americans Independence Center; Director, Brigham Research Assay Core Laboratory; Director, Research Program in Men's Health: Aging and Metabolism; and Co-Director, The Center for Transgender Health at Brigham and Women's Hospital, presented the 2022 Beverly Todd Towery Lecture, "A Patient-Centric, Evidence-based Approach to the Management of Older Men with Age-Related Decline in Testosterone Levels" at University of Louisville Department of Medicine Grand Rounds on March 3, 2022

Dr. Bhasin's talk focused on recognizing the potential benefits and risks of testosterone treatment in older men, determining which older men might be candidates for testosterone treatment, and establishing a standardized monitoring plan to optimize the benefit to risk ratio.

Presented by the UofL Division of Endocrinology, Metabolism & Diabetes







View attachment 20041
View attachment 20042
View attachment 20043
View attachment 20044
View attachment 20045
View attachment 20046
View attachment 20047
I do find it unfortunate that in response to the final question Dr. Bhasin gives the bad advice that for any elective surgical procedure testosterone should be stopped for a week prior.....
 

hCG Mixing Calculator

HCG Mixing Protocol Calculator

TRT Hormone Predictor Widget

TRT Hormone Predictor

Predict estradiol, DHT, and free testosterone levels based on total testosterone

⚠️ Medical Disclaimer

This tool provides predictions based on statistical models and should NOT replace professional medical advice. Always consult with your healthcare provider before making any changes to your TRT protocol.

ℹ️ Input Parameters

Normal range: 300-1000 ng/dL

Predicted Hormone Levels

Enter your total testosterone value to see predictions

Results will appear here after calculation

Understanding Your Hormones

Estradiol (E2)

A form of estrogen produced from testosterone. Important for bone health, mood, and libido. Too high can cause side effects; too low can affect well-being.

DHT

Dihydrotestosterone is a potent androgen derived from testosterone. Affects hair growth, prostate health, and masculinization effects.

Free Testosterone

The biologically active form of testosterone not bound to proteins. Directly available for cellular uptake and biological effects.

Scientific Reference

Lakshman KM, Kaplan B, Travison TG, Basaria S, Knapp PE, Singh AB, LaValley MP, Mazer NA, Bhasin S. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab. 2010 Aug;95(8):3955-64.

DOI: 10.1210/jc.2010-0102 | PMID: 20534765 | PMCID: PMC2913038

Beyond Testosterone Podcast

Online statistics

Members online
8
Guests online
1,583
Total visitors
1,591

Latest posts

Back
Top